These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7893930

  • 1. Large-scale preparation and biochemical characterization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography.
    Feldman PA, Bradbury PI, Williams JD, Sims GE, McPhee JW, Pinnell MA, Harris L, Crombie GI, Evans DR.
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):939-48. PubMed ID: 7893930
    [Abstract] [Full Text] [Related]

  • 2. Removal and inactivation of enveloped and non-enveloped viruses during the purification of a high-purity factor IX by metal chelate affinity chromatography.
    Roberts PL, Walker CP, Feldman PA.
    Vox Sang; 1994 Dec; 67 Suppl 1():69-71. PubMed ID: 8091741
    [Abstract] [Full Text] [Related]

  • 3. Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography.
    Burnouf T, Michalski C, Goudemand M, Huart JJ.
    Vox Sang; 1989 Dec; 57(4):225-32. PubMed ID: 2617959
    [Abstract] [Full Text] [Related]

  • 4. Large-scale production and properties of a solvent-detergent-treated factor IX concentrate from human plasma.
    Michalski C, Bal F, Burnouf T, Goudemand M.
    Vox Sang; 1988 Dec; 55(4):202-10. PubMed ID: 3265237
    [Abstract] [Full Text] [Related]

  • 5. [Blood protein technological industrial developments as a mirror of fundamental studies bgy the Institute of Biochemistry of the Ukrainian National Academy of Sciences].
    Volkov GL, Andrianov SI, Horoshnykova TV, Borysevych OS, Gavryliuk OS.
    Ukr Biokhim Zh (1999); 2000 Dec; 72(4-5):109-21. PubMed ID: 11200439
    [Abstract] [Full Text] [Related]

  • 6. Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicity.
    Gray E, Tubbs J, Thomas S, Oates A, Boisclair M, Kemball-Cook G, Barrowcliffe TW.
    Thromb Haemost; 1995 Apr; 73(4):675-9. PubMed ID: 7495077
    [Abstract] [Full Text] [Related]

  • 7. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
    Johnston A, Macgregor A, Borovec S, Hattarki M, Stuckly K, Anderson D, Goss NH, Oates A, Uren E.
    Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439
    [Abstract] [Full Text] [Related]

  • 8. Human factor IX and factor IXa.
    Bajaj SP, Birktoft JJ.
    Methods Enzymol; 1993 Sep; 222():96-128. PubMed ID: 8412817
    [No Abstract] [Full Text] [Related]

  • 9. Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex.
    Liebman HA, Limentani SA, Furie BC, Furie B.
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3879-83. PubMed ID: 2408269
    [Abstract] [Full Text] [Related]

  • 10. A cross-over pharmacokinetic and thrombogenicity study of a prothrombin complex concentrate and a purified factor IX concentrate.
    Thomas DP, Hampton KK, Dasani H, Lee CA, Giangrande PL, Harman C, Lee ML, Preston FE.
    Br J Haematol; 1994 Aug; 87(4):782-8. PubMed ID: 7986719
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preparation and properties of a therapeutic factor IX concentrate.
    Suomela H, Myllylä G, Raaska E.
    Vox Sang; 1977 Jul; 33(1):37-50. PubMed ID: 883244
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of factor IX BM. Difference of cleavage sites by factor XIa and Ca2+ in factor IX Kashihara, factor IX Nagoya and factor IX Niigata.
    Yoshioka A, Ohkubo Y, Nishimura T, Tanaka I, Fukui H, Ogata K, Kamiya T, Takahashi H.
    Thromb Res; 1986 Jun 01; 42(5):595-604. PubMed ID: 3487139
    [Abstract] [Full Text] [Related]

  • 18. Purification of human factor IX by chromatography of a coagulation factor concentrate.
    Suomela H.
    Thromb Haemost; 1976 Feb 29; 35(1):211-21. PubMed ID: 989188
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunoaffinity purification of factor IX from commercial concentrates and infusion studies in animals.
    Smith KJ.
    Blood; 1988 Oct 29; 72(4):1269-77. PubMed ID: 3262386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.